ATM was originally identified in individuals with ataxia-telangiectasis (AT), an autosomal recessive disorder that manifests with progressive ataxia, telangiectasia, immunodeficiency, genomic instability, and cancer predisposition (57). This evidence concerns the gene ATM and immunodeficiency disease.